Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy
about
Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy.Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy.Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle.Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD).Elevated phosphodiester and T2 levels can be measured in the absence of fat infiltration in Duchenne muscular dystrophy patients.
P2860
Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Histologic muscular history in ...... tients with Duchenne dystrophy
@ast
Histologic muscular history in ...... tients with Duchenne dystrophy
@en
type
label
Histologic muscular history in ...... tients with Duchenne dystrophy
@ast
Histologic muscular history in ...... tients with Duchenne dystrophy
@en
prefLabel
Histologic muscular history in ...... tients with Duchenne dystrophy
@ast
Histologic muscular history in ...... tients with Duchenne dystrophy
@en
P2093
P2860
P50
P1433
P1476
Histologic muscular history in ...... tients with Duchenne dystrophy
@en
P2093
Chiara Favero
Lucia Morandi
Luisa Villa
Silvia Testolin
P2860
P304
P356
10.1212/WNL.0000000000002147
P407
P50
P577
2015-10-23T00:00:00Z